Skip to main navigation
Lineage Cell Therapeutics
  • Company
    • About Us
    • Leadership
    • Board of Directors
    • Careers
    • Contact
  • Products & Pipeline
    • OpRegen®
    • OPC1
    • VAC2
    • Renevia
  • Technologies
    • Cell Therapy
    • Other Technologies
      • Vision Restoration Programs
      • MS/Stroke Programs
      • HyStem® Delivery Technology
      • Renevia®
    • Patents & Trade Secrets
    • Scientific Publications
  • Media
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxy Information
      • 2018 AgeX and Form 10 Information Statement
      • 2019 Form 8937
    • E-mail Alerts
    • Contact IR
  • Menu

Press Releases

Investor Relations

  • Investors Overview
  • Press Releases
  • Events and Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
  • Analyst Coverage
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
  • Financials & Filings
    • SEC Filings
    • Annual Report and Proxy Information
    • 2018 AgeX Form 10 and Information Statement
    • 2019 Form 8937
  • E-mail Alerts
  • Contact IR

Press Releases

February 23, 2021
Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2021 and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021
February 16, 2021
Lineage to Host Virtual OPC1 Investor & Analyst Day on February 22, 2021
February 8, 2021
Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury
January 21, 2021
Lineage Posts Series of Webinars Highlighting Recent Progress With its Three Clinical-Stage Allogeneic Cell Transplant Programs
January 20, 2021
Lineage Cell Therapeutics Announces Change to Executive Team
© Copyright - Lineage Cell Therapeutics, Inc.   |   Terms of Use & Privacy   |   contact@lineagecell.com
  • Facebook
  • Twitter
  • RSS Feed
  • Email Alerts
Scroll to top